Match!

Abstract LB-170: Breast cancer incidence and hormone therapy use before and after the Women’s Health Initiative (WHI) estrogen (E) plus progestin (P) trial by race/ethnicity

Published on Jul 1, 2019in Epidemiology4.72
· DOI :10.1158/1538-7445.sabcs18-lb-170
Rowan T. Chlebowski77
Estimated H-index: 77
,
Aaron K. Aragaki43
Estimated H-index: 43
+ 1 AuthorsRoss L. Prentice90
Estimated H-index: 90
  • References (0)
  • Citations (0)
References0
Newest
Cited By0
Newest
View next paperEstrogen-Progestin Therapy and Risk for Breast Cancer: More Findings from the WHI